Detalhe da pesquisa
1.
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer.
Res Sq
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746324
2.
Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.
Cancer Med
; 10(15): 5163-5174, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159748
3.
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays.
Am J Surg Pathol
; 45(9): 1274-1281, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115674
4.
Measuring Tumor Epichaperome Expression Using [124I] PU-H71 Positron Emission Tomography as a Biomarker of Response for PU-H71 Plus Nab-Paclitaxel in HER2-Negative Metastatic Breast Cancer.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33283132
5.
Atypical response with bone pseudoprogression in a patient receiving nivolumab for advanced cutaneous squamous cell carcinoma.
J Immunother Cancer
; 6(1): 130, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30482243